Valvular & structural heart disease
Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry
Authors' conclusion
Patients were often referred late in the disease process, with few patients undergoing early intervention.
Study context
- Population
- Consecutive adults undergoing isolated or combined mitral valve surgery for mitral regurgitation (MR) in France or Canada in 2019
- Participants
- 3,522 adults40 centres
- Outcome
- Repair rate and in-hospital mortality after MVS for MR
- Follow-up
- In-hospital
Methodological detailsinternational registry, multicentre, consecutive patients
- International registry
- Multicentre
- Consecutive patients
Main finding
As reported in the abstract
in-hospital
- Repair rate, overall
- 62%
- Repair rate, myxomatous disease
- 80%
- In-hospital mortality, overall
- 4.5%
- In-hospital mortality, myxomatous MR
- 2.3%
- In-hospital mortality, myxomatous MR, isolated mitral valve surgery (MVS)
- 1.8%
- In-hospital mortality, myxomatous MR, combined MVS
- 3.1%
Observational data: associations, not effects.
Original publication
Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry. Circulation. Published 31 August 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →